InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by DiRaimondo Thomas, Chief Scientific Officer. Officer active across 1 company, notably Janux Therapeutics, Inc.. In total, 3 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €208k. Activity tracked since 27 September 2024. The latest transaction was disclosed on 2 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to DiRaimondo Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
2,505 股@ US$13.730.0035% mcap50.0% 占其流量Common StockSEC:0002005618-26-000002:0
24,000 股0Common StockSEC:0001415889-25-000673:0
4,325 股@ US$46.205775.3% 占其流量Common StockSEC:0001415889-24-024076:0
3 条申报中的 3 条
About DiRaimondo Thomas
Thomas DiRaimondo is the Chief Scientific Officer at Janux Therapeutics, Inc. He oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Janux.
